Lung cancer screenings 'a good value,' study finds
Screening longtime tobacco users for lung cancer would be less costly than the widely accepted practice of screening for breast, cervical and colorectal cancers and would reduce the death toll of lung cancer by an estimated 15,000 lives a year, according to a study released Monday that is likely to ignite debate on expanding healthcare coverage for smokers. A group of actuarial economists calculated that annual low-dose CT scans of middle-aged Americans who have smoked the equivalent of a pack of cigarettes every day for 30 years would cost each insured American an extra 76 cents a month. That investment could give each person whose lung cancer was caught early an extra year of life, at a cost of $18,862 per patient.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- Hospitals Likely to Outsource ICD-10 at Launch
- IOM Identifies GME Problems, Calls for Finance Changes
- CMS Confirms ICD-10 Deadline
- Anatomy of 3 Health System Rebranding Efforts
- Premium Subsidy Fight Creating Uncertainty for Hospitals, Health Plans
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts